Where PhDs and companies meet
Menu
Login

Already registered?

New user?

New Novartis R&D centre in China

Fabrice Martin

Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.

Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.

Operations are set to begin in May 2007.